Machine learning can predict the risk for developing asthma and allergic rhinitis in children diagnosed with early-life atopic dermatitis.
VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced the availability of an AI ...
Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced ...
Discover how machine learning asthma prediction can identify high-risk children early and support personalised care ...
SmartAC, the leading B2B platform powering predictive intelligence for HVAC service providers, today announced a major expansion of its technology organization under Chief Technology Officer Matt ...
17hOpinion
Beyond Prediction: Why Financial Services Needs Causal Architecture at the Core of Its AI Models
The results have been impressive by the metrics that matter to technology teams: accuracy rates, processing speeds, cost ...
Artificial intelligence (AI) is emerging as a powerful tool to predict food consumption patterns and guide policy decisions, ...
Predictive modeling is reshaping how businesses anticipate challenges, seize opportunities, and optimize processes. By leveraging machine learning, ensemble methods, and advanced analytics, ...
A new philosophical and socio-technical analysis by Katia Schwerzmann of Ruhr University Bochum argues that contemporary AI ...
The AI in predictive toxicology market is poised for rapid growth driven by increasing AI adoption for safer chemicals, ...
JuliaHub raises $65M Series B and launches Dyad 3.0, bringing Agentic AI to Industrial Digital Twins
Today, JuliaHub announces the launch of Dyad 3.0 and a $65M series B funding round led by Dorilton Capital, with ...
Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results